No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Skin biopsy rates have disproportionately increased compared to cancer treatments between 1993-2016

byTeddy Guo

February 18, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract Bortezomib, cyclophosphamide, and dexamethasone demonstrated a modest median event-free survival in transplant ineligible patients with multiple myeloma

RelatedReports

AI Roundup

Artificial intelligence matches dermatologists in melanoma diagnosis

September 15, 2025

The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Fall boosters, mosquitoes, skin awareness, and Hollywood healing

August 28, 2025

Dermatology

Microneedling with tranexamic acid may improve outcomes for patients with melasma

August 26, 2025

Rapid growth of medical artificial intelligence technology usage identified from insurance claims analysis, yet major barriers to widespread adoption remain

Chronic Disease

Remibrutinib alleviates symptoms in chronic spontaneous urticaria resistant to H1-antihistamines

March 13, 2025

Quick Take: Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent)

Bimekizumab shows better efficacy in treating severe plaque psoriasis than ustekinumab

#VisualAbstract Phase I: Adding carfilzomib to HyperCVAD in patients with newly diagnosed acute lymphoblastic leukemia showed favourable safety and efficacy outcomes

2 Minute Medicine Rewind February 22, 2021

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports